drug pricing reform

“Since 2020, changes in how the program operates have created significant challenges for providers across Illinois. Federally qualified health centers in Illinois have lost at least $60 million because of restrictions,” Moeller said. #centerssquare #pharma

Even with major progress on insulin affordability, many people with diabetes struggle under the weight of a costly system.

Expanding a program that allows profits to grow without transparency while  also delivering minimal benefit to patients at the point-of-sale risks worsening those challenges rather than solving them. #drug #oped

Critics point to financial data suggesting 340B-participating hospitals in Illinois report significantly higher average patient revenues than non-participating hospitals. #drug #proposals #critics